EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Effectiveness of Paroxetine Versus Non‐Paroxetine Selective Serotonin Reuptake Inhibitors on Mortality and Heart Failure Following Myocardial Infarction: An Active Comparator Population‐Based Cohort Study

Thomas Ravn Lassen iD, Péter Szentkúti, Henrik Toft Sørensen, Hans Erik Bøtker, Jens Sundbøll

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70141 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Thomas Ravn Lassen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Paroxetine, Selective Serotonin Reuptake Inhibitors, Heart Failure, Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Klinisk Epidemiologisk Forskningsfond, Aarhus Universitetshospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Animal studies suggest that paroxetine, unlike other selective serotonin reuptake inhibitors (SSRIs), may attenuate post‐myocardial infarction (MI) heart failure. We examine the effectiveness of paroxetine versus non‐paroxetine SSRIs on the risk of post‐MI mortality and heart failure in a clinical setting.

Method

We conducted a nationwide population‐based cohort study based on Danish medical registries. Using an active comparator design, we compared the effectiveness of paroxetine with non‐paroxetine SSRI drugs on post‐MI outcomes. This included all patients hospitalized for MI in Denmark during 1995–2020 who had redeemed an SSRI prescription within 90 days prior to admission and measured outcome variables after a 180‐day follow‐up period. We calculated cumulative incidences as a measure of risk and used Cox regression to compute hazard ratios (HRs) for all outcomes, adjusting for sex, age group, individual comorbidities, and comedications.

Results

We identified 13 053 patients receiving treatment with an SSRI at the time of hospital admission for MI. Cumulative incidences were lower for paroxetine SSRI users compared with non‐paroxetine SSRI users for all‐cause mortality (24.7% versus 33.8% (difference: −9.1% [95% CI: −12.4; −5.8])) and cardiovascular death (15.9% versus 22.7% (−6.8% [95% CI: −9.6; −4.0])), but not for heart failure (11.0% versus 11.8% (−0.7% [95% CI: −3.13; 1.65])). Adjusted hazard ratios (aHRs) showed no substantial differences for all‐cause mortality (aHR 0.9 [95% CI: 0.8–1.1]), cardiovascular death (aHR 0.9 [95% CI: 0.8–1.1]), or heart failure (aHR 1.0 [95% CI: 0.8–1.3]).

Conclusion

Paroxetine was not associated with clinically significant improvement in post‐MI outcomes compared with non‐paroxetine SSRI drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParoxetineSelective Serotonin Reuptake InhibitorsHeart FailureMyocardial InfarctionHumansMaleFemaleDenmarkAgedMiddle AgedCohort StudiesRegistriesIncidenceHospitalizationAged, 80 and overFollow-Up StudiesAdult

Stichwörter der Autor:innen

heart failuremyocardial infarctionselective serotonin reuptake inhibitors

Substanzen

ParoxetineSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
  • Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Medicine, Randers Regional Hospital, Randers, Denmark.
  • Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark.
  • Department of Cardiology, Goedstrup Hospital, Herning, Denmark.

ORCID-Profile: Thomas Ravn Lassen

Förderung

  • Klinisk Epidemiologisk Forskningsfond, Aarhus Universitetshospital

Zitieren

APA

Lassen, T. R., Szentkúti, P., Sørensen, H. T., Bøtker, H. E., & Sundbøll, J. (2025). Effectiveness of Paroxetine Versus Non‐Paroxetine Selective Serotonin Reuptake Inhibitors on Mortality and Heart Failure Following Myocardial Infarction: An Active Comparator Population‐Based Cohort Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70141

Vancouver

Lassen TR, Szentkúti P, Sørensen HT, Bøtker HE, Sundbøll J. Effectiveness of Paroxetine Versus Non‐Paroxetine Selective Serotonin Reuptake Inhibitors on Mortality and Heart Failure Following Myocardial Infarction: An Active Comparator Population‐Based Cohort Study. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70141

BibTeX
@article{Lassen2025,
  author = {Lassen, Thomas Ravn and Szentkúti, Péter and Sørensen, Henrik Toft and Bøtker, Hans Erik and Sundbøll, Jens},
  title = {Effectiveness of Paroxetine Versus Non‐Paroxetine Selective Serotonin Reuptake Inhibitors on Mortality and Heart Failure Following Myocardial Infarction: An Active Comparator Population‐Based Cohort Study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70141}
}
Kostenlos starten →